Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2018 Jan 1.

Published in final edited form as: Macromol Biosci. 2016 Jul 1;17(1):10.1002/mabi.201600194. doi: 10.1002/mabi.201600194

Fig. 2 — Fig. 2A: Effect of PTX alone, dual drug combinations, and Triolimus at 2 nM on A549 clonogenic survival (*: P<0.001, **: P<0.01, ***: P<0.05)

Fig. 2B: Effects of PTX alone, dual drug combinations, and Triolimus on radiosensitivity at 2 nM (black circle: no treatment, open circle: PTX, open square: Triolimus, open diamond: P/17, open triangle: P/R, open inverse triangle: 17/R (*: P<0.01, **: P<0.05)

Fig. 2 — Fig. 2A: Effect of PTX alone, dual drug combinations, and Triolimus at 2 nM on A549 clonogenic survival (*: P<0.001, **: P<0.01, ***: P<0.05)

Fig. 2B: Effects of PTX alone, dual drug combinations, and Triolimus on radiosensitivity at 2 nM (black circle: no treatment, open circle: PTX, open square: Triolimus, open diamond: P/17, open triangle: P/R, open inverse triangle: 17/R (*: P<0.01, **: P<0.05)

HHS Vulnerability Disclosure